体外診断薬の世界市場:製品別、技術別(分子診断、臨床化学)、用途別、エンドユーザー別

【英語タイトル】In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product, By Technology (Molecular Diagnostics, Clinical Chemistry), By Application, By End Use, And Segment Forecast, 2020 - 2027

Grand View Researchが出版した調査資料(GVR20MA087)・商品コード:GVR20MA087
・発行会社(調査会社):Grand View Research
・発行日:2020年2月11日
・ページ数:159
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:臨床診断
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥624,750見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥729,750見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥939,750見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、体外診断薬の世界市場について調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場の要因・動向・範囲、競争分析、製品別(機器、試薬、サービス)分析、技術別(免疫測定法、血液学、臨床化学、分子診断、凝固)分析、用途別(感染症、糖尿病、腫瘍学、循環器、腎臓病)分析、エンドユーザー別(病院、研究所、ホームケア、その他)分析、地域別分析、競争状況などの構成でお届けいたします。
・調査手法・範囲
・エグゼクティブサマリー
・市場の要因・動向・範囲
・競争分析
・体外診断薬の世界市場:製品別(機器、試薬、サービス)
・体外診断薬の世界市場:技術別(免疫測定法、血液学、臨床化学、分子診断、凝固)
・体外診断薬の世界市場:用途別(感染症、糖尿病、腫瘍学、循環器、腎臓病)
・体外診断薬の世界市場:エンドユーザー別(病院、研究所、ホームケア、その他)
・体外診断薬の世界市場:地域別
・競争状況
【レポートの概要】

The global in vitro diagnostics (IVD) market is expected to reach USD 85.8 billion by 2027, according to a new report by Grand View Research, Inc. It is projected to exhibit a 4.4% CAGR over the forecast period. Development of simplified diagnostic tests is expected to drive the growth. For instance, Cepheid’s Xpert HCV VL Fingerstick received CE-IVD clearance in September 2018. This test identifies and measures HCV RNA levels from fingerstick blood sample.

Key players are developing new products and undertaking strategic initiatives, such as collaborations, mergers and acquisitions to gain greater market share and to expand their product portfolio. For instance, in February 2018, a product named PAXgene Blood ccfDNA tube was made available by BD for non-invasive prenatal testing and cancer diagnosis and application in the European Economic Area (EEA) and Switzerland. PAXgene Blood ccfDNA tube was developed by Qiagen-PreAnalytiX GmbH and BD in a joint venture.

Rising geriatric population and favorable government regulations to spur the approval process of medical devices are the factors expected to drive the market over the forecast period. For instance, in August 2018, approval process for IVD was eased in an amended provision in the Fourth Schedule of Medical Devices Rule by the central government of India.

Furthermore, increasing demand for early diagnosis to strategize complete treatment plans for patients by the physicians is projected to fuel the demand for user-friendly in vitro diagnostic products. For instance, in July 2017, bioMerieux for VITEK MS received the U.S. Food and Drug Administration (FDA) approval. It is a mass spectrometry system that rapidly identifies pathogens, such as Nocardia mycobacteria, and molds.

Reagents held the largest market share in 2019, owing to development of analytical laboratory automation coupled with high usage rate of reagents. For instance, in July 2018, Surmodics, Inc. launched MatrixGuard Diluent that blocks matrix or assay signal and maintains intended signals.

Increasing prevalence cancer, cardiovascular disorders, diabetes, and other diseases is expected to accelerate the demand for in vitro diagnostics in the forthcoming years. According to Cancer Research UK, in 2018, about 17 million new cancer cases were reported across the world. It has estimated that the incidence rate of the disease will witness a 62% rise from 2018 to 2040. Liver, stomach, breast, lung, and colorectal are the most common types of cancer.

Further key findings from the report suggest:

• Molecular diagnostics segment is expected to witness the fastest growth over the forecast period, owing to the high usage of the technology for disease diagnosis

• Infectious disease application segment dominated the market in 2019 due to rising prevalence of tuberculosis, hepatitis, and other infectious diseases

• North America dominated the in vitro diagnostics market in 2019, owing to presence of key players and a rise in launch of new products in major countries like U.S. and Canada

• Asia Pacific is expected to exhibit the fastest CAGR over the forecast period owing to number of products are being launched in hospitals to provide accurate diagnosis

• Major IVD market players are Qiagen; Danaher; Becton, Dickinson and Company; Siemens Healthineers; F. Hoffmann-La Roche Ltd.; Hologic, Inc. (Gen-Probe); bioMerieux SA; Abbott Laboratories; Cepheid; and Sysmex Corporation

【レポートの目次】

Table of Contents

Chapter 1 Methodology and Scope
1.1. Research Methodology
1.2. Market segmentation & scope
1.3. Market definition
1.4. Information procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources & third party perspectives
1.4.4. Primary research
1.5. Information analysis
1.5.1. Data analysis models
1.6. Market formulation & data visualization
1.7. Data validation & publishing
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Global IVD Market Variables, Trends & Scope
3.1. IVD Market Lineage outlook
3.1.1. Medical Technology market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Regulatory Framework
3.3.1. Reimbursement framework
3.3.2. Standards & Compliances
3.4. Market Dynamics
3.4.1. Market Driver Analysis
3.4.1.1. Increasing demand for point of care diagnostics
3.4.1.2. Growing geriatric population
3.4.1.3. Introduction of technologically advanced diagnostics
3.4.1.4. Increasing prevalence of chronic diseases
3.4.2. Market Restraint Analysis
3.4.2.1. High cost of devices
3.4.2.2 Stringent regulatory policies
3.5. Global IVD Market Analysis Tools
3.5.1. Industry Analysis – Porter’s
3.5.1.1. Supplier Power: (Moderate to high due to presence of many manufacturers)
3.5.1.2. Buyer Power: (Low due to presence of primary clinics and diagnostic labs entering into long-term contract)
3.5.1.3. Substitution Threat: (Moderate to Low due to high Accuracy of diagnostic results)
3.5.1.4. Threat from new entrant: (Moderate due to brand recognition of the existing players)
3.5.1.5. Competitive rivalry: (High due to increasing mergers & acquisitions by major players)
3.5.2. PESTEL Analysis
3.5.2.1. Political Landscape
3.5.2.2. Environmental Landscape
3.5.2.3. Social Landscape
3.5.2.4. Technology Landscape
3.5.2.5. Legal Landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.3.1. Joint Ventures
3.5.3.2. Mergers & Acquisitions
3.5.3.3. Licensing & Partnership
3.5.3.4. Technology Collaborations
3.5.3.5. Strategic Divestments
Chapter 4. Global IVD Market – Competitive Analysis
4.1. Recent developments & impact analysis, by key market participants
4.2. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
4.3. Vendor Landscape
4.3.1. List of key distributors and channel partners
4.3.2. Key company market share analysis, 2019
4.4. Public Companies
4.4.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
4.4.2. Company Market Share
4.4.3. Competitive Dashboard Analysis
4.4.4. Market Differentiators
4.4.5. Synergy Analysis: Major Deals & Strategic Alliances
4.5. Private Companies
4.5.1. List of key emerging companies
4.5.2. Regional network map
4.5.3. Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
Chapter 5. Global IVD Market: Product Estimates & Trend Analysis
5.1. Definitions & Scope
5.2. Global IVD Market, by Product, 2016 – 2027
5.3. Market Size & Forecasts and Trend Analyses, 2016 – 2027 for the following,
5.3.1. Instruments
5.3.1.1 Instrument IVD Market, 2016 – 2027 (USD Million)
5.3.2. Reagents
5.3.1.1 Reagents IVD Market, 2016 – 2027 (USD Million)
5.3.3. Services
5.3.1.1 Services IVD Market, 2016 – 2027 (USD Million)
Chapter 6. Global IVD Market: Technology Estimates & Trend Analysis
6.1. Definitions & Scope
6.2. Technology market share analysis, 2019 & 2027
6.3. Global IVD Market, by Technology, 2016 to 2027
6.4. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following,
6.4.1. Immunoassay
6.4.1.1 Immunoassay IVD Market, 2016 – 2027 (USD Million)
6.4.2. Hematology
6.4.2.1 Hematology IVD Market, 2016 – 2027 (USD Million)
6.4.3. Clinical Chemistry
6.4.3.1 Clinical Chemistry IVD Market, 2016 – 2027 (USD Million)
6.4.4. Molecular Diagnostics
6.4.4.1 Molecular Diagnostics IVD Market, 2016 – 2027 (USD Million)
6.4.5. Coagulation
6.4.5.1 Coagulation IVD Market, 2016 – 2027 (USD Million)
6.4.6. Microbiology
6.4.6.1 Microbiology IVD Market, 2016 – 2027 (USD Million)
6.4.7. Others
6.4.7.1 Others IVD Market, 2016 – 2027 (USD Million)
6.5. Technology Markets, by Product, 2016 to 2027:
6.5.1. Immunoassay
6.5.1.1 Instruments
6.5.1.1.1 Instrument IVD Market, 2016 – 2027 (USD Million)
6.5.2.1 Reagents
6.5.2.1.1 Reagents IVD Market, 2016 – 2027 (USD Million)
6.5.3.1 Services
6.5.3.1.1 Services IVD Market, 2016 – 2027 (USD Million)
6.5.2. Hematology
6.5.2.1 Instruments
6.5.2.1.1 Instrument IVD Market, 2016 – 2027 (USD Million)
6.5.2.2. Reagents
6.5.2.2.1 Reagents IVD Market, 2016 – 2027 (USD Million)
6.5.2.3 Services
6.5.2.3.1 Services IVD Market, 2016 – 2027 (USD Million)
6.5.3. Clinical Chemistry
6.5.3.1 Instruments
6.5.3.1.1 Instrument IVD Market, 2016 – 2027 (USD Million)
6.5.3.2. Reagents
6.5.3.2.1 Reagents IVD Market, 2016 – 2027 (USD Million)
6.5.3.3 Services
6.5.3.3.1 Services IVD Market, 2016 – 2027 (USD Million)
6.5.4. Molecular Diagnostics
6.5.4.1 Instruments
6.5.4.1.1 Instrument IVD Market, 2016 – 2027 (USD Million)
6.5.4.2. Reagents
6.5.4.2.1 Reagents IVD Market, 2016 – 2027 (USD Million)
6.5.4.3 Services
6.5.4.3.1 Services IVD Market, 2016 – 2027 (USD Million)
6.5.5. Coagulation
6.5.5.1 Instruments
6.5.5.1.1 Instrument IVD Market, 2016 – 2027 (USD Million)
6.5.5.2. Reagents
6.5.5.2.1 Reagents IVD Market, 2016 – 2027 (USD Million)
6.5.5.3 Services
6.5.5.3.1 Services IVD Market, 2016 – 2027 (USD Million)
6.5.6. Microbiology
6.5.6.1 Instruments
6.5.6.1.1 Instrument IVD Market, 2016 – 2027 (USD Million)
6.5.6.2. Reagents
6.5.6.2.1 Reagents IVD Market, 2016 – 2027 (USD Million)
6.5.6.3 Services
6.5.6.3.1 Services IVD Market, 2016 – 2027 (USD Million)
6.5.7. Others
6.5.7.1 Instruments
6.5.7.1.1 Instrument IVD Market, 2016 – 2027 (USD Million)
6.5.7.2. Reagents
6.5.7.2.1 Reagents IVD Market, 2016 – 2027 (USD Million)
6.5.7.3 Services
6.5.7.3.1 Services IVD Market, 2016 – 2027 (USD Million)
Chapter 7. Global IVD Market: Application Estimates & Trend Analysis
7.1. Definitions & Scope
7.2. Application market share analysis, 2019 & 2027
7.3. Global IVD Market, by Application, 2016 to 2027
7.4. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following,
7.4.1. Infectious Disease
7.4.1.1 Infectious Disease IVD Market, 2016 – 2027 (USD Million)
7.4.2. Diabetes
7.4.2.1 Diabetes IVD Market, 2016 – 2027 (USD Million)
7.4.3. Oncology
7.4.3.1 Oncology IVD Market, 2016 – 2027 (USD Million)
7.4.4. Cardiology
7.4.4.1 Cardiology IVD Market, 2016 – 2027 (USD Million)
7.4.5. Nephrology
7.4.5.1 Nephrology IVD Market, 2016 – 2027 (USD Million)
7.4.6. Autoimmune Disease
7.4.6.1 Autoimmune Disease IVD Market, 2016 – 2027 (USD Million)
7.4.7. Drug Testing
7.4.7.1 Drug Testing IVD Market, 2016 – 2027 (USD Million)
7.4.8. Others
7.4.8.1 Others IVD Market, 2016 – 2027 (USD Million)
Chapter 8. Global IVD Market: End Use Estimates & Trend Analysis
8.1. Definitions & Scope
8.2. End Use market share analysis, 2019 & 2027
8.3. Global IVD Market, by End Use, 2016 to 2027
8.4. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following,
8.4.1. Hospitals
8.4.1.1 Instrument IVD Market, 2016 – 2027 (USD Million)
8.4.2. Laboratories
8.4.2.1 Instrument IVD Market, 2016 – 2027 (USD Million)
8.4.3. Home Care
8.4.3.1 Instrument IVD Market, 2016 – 2027 (USD Million)
8.4.4. Others
8.4.4.1 Instrument IVD Market, 2016 – 2027 (USD Million)
Chapter 9 Global IVD Market: Regional Estimates & Trend Analysis, by Product, Technology, Application, & End-use
9.1 Global IVD Market: Regional Movement Analysis, 2019 & 2027
9.2 Global IVD Market: Leading Players, 2019:
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3 SWOT Analysis, by Factor (Political & Legal, Economic And Technological)
9.3.1. North America
9.3.2. Europe
9.3.3. Asia Pacific
9.3.4. Latin America
9.3.5. Middle East & Africa
9.4 North America
9.4.1 North America IVD market, 2016 – 2027 (USD Million)
9.4.2 U.S.
9.4.2.1 U.S. IVD Market, 2016 – 2027 (USD Million)
9.4.3 Canada
9.4.3.1 Canada IVD Market, 2016 – 2027 (USD Million)
9.5. Europe
9.5.1 Europe IVD market, 2016 – 2027 (USD Million)
9.5.3 U.K.
9.5.3.1 U.K. IVD market, 2016 – 2027 (USD Million)
9.5.2 Germany
9.5.2.1 Germany IVD market, 2016 – 2027 (USD Million)
9.5.3 Spain
9.5.3.1 Spain IVD market, 2016 – 2027 (USD Million)
9.5.3 France
9.5.3.1 France IVD market, 2016 – 2027 (USD Million)
9.5.3 Italy
9.5.3.1 Italy IVD market, 2016 – 2027 (USD Million)
9.5.3 Russia
9.5.3.1 Russia IVD market, 2016 – 2027 (USD Million)
9.6 Asia Pacific
9.6.1 Asia Pacific IVD market, 2016 – 2027 (USD Million)
9.6.2 Japan
9.6.2.1 Japan IVD market, 2016 – 2027 (USD Million)
9.6.3 India
9.6.3.1 India IVD market, 2016 – 2027 (USD Million)
9.6.4 South Korea
9.6.4.1 South Korea IVD market, 2016 – 2027 (USD Million)
9.6.5 Singapore
9.6.5.1 Singapore IVD market, 2016 – 2027 (USD Million)
9.6.6 Australia
9.6.6.1 Australia IVD market, 2016 – 2027 (USD Million)
9.7 Latin America
9.7.1 Latin America IVD market, 2016 – 2027 (USD Million)
9.7.2 Brazil
9.7.2.1 Brazil IVD market, 2016 – 2027 (USD Million)
9.7.3 Mexico
9.7.3.1 Mexico IVD market, 2016 – 2027 (USD Million)
9.7.4 Argentina
9.7.4.1 Argentina IVD market, 2016 – 2027 (USD Million)
9.8 MEA
9.8.1 MEA IVD market, 2016 – 2027 (USD Million)
9.8.2 South Africa
9.8.2.1 South Africa IVD market, 2016 – 2027 (USD Million)
9.8.3 United Arab Emirates
9.8.3.1 United Arab Emirates IVD market, 2016 – 2027 (USD Million)
9.8.4 Saudi Arabia
9.8.4.1 Saudi Arabia IVD market, 2016 – 2027 (USD Million)
Chapter 10 Competitive Landscape
10.1 Strategy Framework
10.2 Heat Map Analysis of Private Companies
10.2.1 Company size
10.2.2 Distribution network
10.2.3 Product portfolio
10.2.4 Segment coverage
10.2.5 Geographic presence
10.2.6 Collaborations
10.2.7 Conclusion
10.3 Becton, Dickinson and Company
10.3.1 Company overview
10.3.2 Financial performance
10.3.3 Product benchmarking
10.3.4 Strategic initiatives
10.4 bioMerieux
10.4.1 Company overview
10.4.2 Financial performance
10.4.3 Product benchmarking
10.4.4 Strategic initiatives
10.5 Abbott Laboratories
10.5.1 Company overview
10.5.2 Financial performance
10.5.3 Product benchmarking
10.5.4 Strategic initiatives
10.6 Sysmex Corporation
10.6.1 Company overview
10.6.2 Financial performance
10.6.3 Product benchmarking
10.6.4 Strategic initiatives
10.7 Ortho Clinical Diagnostics
10.7.1 Company overview
10.7.2 Financial performance
10.7.3 Product benchmarking
10.7.4 Strategic initiatives
10.8 Danaher
10.8.1 Company overview
10.8.2 Financial performance
10.8.3 Product benchmarking
10.8.4 Strategic initiatives
10.9 Hologic, Inc. (Gen Probe)
10.9.1 Company overview
10.9.2 Financial performance
10.9.3 Product benchmarking
10.9.4 Strategic initiatives
10.10 Cepheid
10.10.1 Company overview
10.10.2 Product benchmarking
10.10.3 Strategic initiatives
10.11 F. Hoffmann-La Roche Ltd
10.11.1 Company Overview
10.11.2 Financial performance
10.11.3 Product benchmarking
10.11.4 Strategic initiatives
10.12 Siemens Healthineers
10.12.1 Company overview
10.12.2 Financial performance
10.12.3 Product benchmarking
10.12.4 Strategic initiatives
10.13 Instrumentation Laboratory
10.13.1 Company overview
10.13.2 Financial overview
10.13.3 Product benchmarking
10.13.4 Strategic initiatives
10.14 Leica Biosystems Nussloch Gmbh
10.14.1 Company overview
10.14.2 Product benchmarking
10.14.3 Strategic initiatives
10.15 Bio-Rad Laboratories, Inc.
10.15.1 Company overview
10.15.2 Financial performance
10.15.3 Product benchmarking
10.15.4 Strategic initiatives
10.16 Quidel Corporation
10.16.1 Company overview
10.16.2 Financial performance
10.16.3 Products benchmarking
10.16.4 Strategic initiatives
10.17 Qiagen N.V.
10.17.1 Company overview
10.17.2 Financial performance
10.17.3 Product benchmarking
10.17.4 Strategic initiatives
10.18 OraSure Technologies, Inc.
10.18.1 Company overview
10.18.2 Financial performance
10.18.3 Products benchmarking
10.18.4 Strategic initiatives
10.19 Stago
10.19.1 Company overview
10.19.2 Product benchmarking
10.19.3 Strategic initiatives

List of Tables

TABLE 1 North America IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 2 North America IVD Market, by Technique, 2016 - 2027 (USD Million)
TABLE 3 North America Immunoassay IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 4 North America Hematology IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 5 North America Clinical Chemistry IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 6 North America Molecular Diagnostics IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 7 North America Coagulation IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 8 North America Microbiology IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 9 North America Others IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 10 North America IVD Market, by Application, 2016 - 2027 (USD Million)
TABLE 11 North America IVD Market, by End-use, 2016 - 2027 (USD Million)
TABLE 12 U.S. IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 13 U.S. IVD Market, by Technique, 2016 - 2027 (USD Million)
TABLE 14 U.S. Immunoassay IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 15 U.S. Hematology IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 16 U.S. Clinical Chemistry IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 17 U.S. Molecular Diagnostics IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 18 U.S. Coagulation IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 19 U.S. Microbiology IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 20 U.S. Others IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 21 U.S. IVD Market, by Application, 2016 - 2027 (USD Million)
TABLE 22 U.S. IVD Market, by End-use, 2016 - 2027 (USD Million)
TABLE 23 Canada IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 24 Canada IVD Market, by Technique, 2016 - 2027 (USD Million)
TABLE 25 Canada Immunoassay IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 26 Canada Hematology IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 27 Canada Clinical Chemistry IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 28 Canada Molecular Diagnostics IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 29 Canada Coagulation IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 30 Canada Microbiology IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 31 Canada Others IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 32 Canada IVD Market, by Application, 2016 - 2027 (USD Million)
TABLE 33 Canada IVD Market, by End-use, 2016 - 2027 (USD Million)
TABLE 34 Europe IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 35 Europe IVD Market, by Technique, 2016 - 2027 (USD Million)
TABLE 36 Europe Immunoassay IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 37 Europe Hematology IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 38 Europe Clinical Chemistry IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 39 Europe Molecular Diagnostics IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 40 Europe Coagulation IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 41 Europe Microbiology IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 42 Europe Others IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 43 Europe IVD Market, by Application, 2016 - 2027 (USD Million)
TABLE 44 Europe IVD Market, by End-use2016 - 2027 (USD Million)
TABLE 45 U.K. IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 46 U.K. IVD Market, by Technique, 2016 - 2027 (USD Million)
TABLE 47 U.K. Immunoassay IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 48 U.K. Hematology IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 49 U.K. Clinical Chemistry IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 50 U.K. Molecular Diagnostics IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 51 U.K. Coagulation IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 52 U.K. Microbiology IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 53 U.K. Others IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 54 U.K. IVD Market, by Application, 2016 - 2027 (USD Million)
TABLE 55 U.K. IVD Market, by End-use, 2016 - 2027 (USD Million)
TABLE 56 Germany IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 57 Germany IVD Market, by Technique, 2016 - 2027 (USD Million)
TABLE 58 Germany Immunoassay IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 59 Germany Hematology IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 60 Germany Clinical Chemistry IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 61 Germany Molecular Diagnostics IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 62 Germany Coagulation IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 63 Germany Microbiology IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 64 Germany Others IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 65 Germany IVD Market, by Application, 2016 - 2027 (USD Million)
TABLE 66 Germany IVD Market, by End-use, 2016 - 2027 (USD Million)
TABLE 67 Spain IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 68 Spain IVD Market, by Technique, 2016 - 2027 (USD Million)
TABLE 69 Spain Immunoassay IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 70 Spain Hematology IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 71 Spain Clinical Chemistry IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 72 Spain Molecular Diagnostics IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 73 Spain Coagulation IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 74 Spain Microbiology IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 75 Spain Others IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 76 Spain IVD Market, by Application, 2016 - 2027 (USD Million)
TABLE 77 Spain IVD Market, by End-use, 2016 - 2027 (USD Million)
TABLE 78 France IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 79 France IVD Market, by Technique, 2016 - 2027 (USD Million)
TABLE 80 France Immunoassay IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 81 France Hematology IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 82 France Clinical Chemistry IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 83 France Molecular Diagnostics IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 84 France Coagulation IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 85 France Microbiology IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 86 France Others IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 87 France IVD Market, by Application, 2016 - 2027 (USD Million)
TABLE 88 France IVD Market, by End-use, 2016 - 2027 (USD Million)
TABLE 89 Italy IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 90 Italy IVD Market, by Technique, 2016 - 2027 (USD Million)
TABLE 91 Italy Immunoassay IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 92 Italy Hematology IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 93 Italy Clinical Chemistry IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 94 Italy Molecular Diagnostics IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 95 Italy Coagulation IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 96 Italy Microbiology IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 97 Italy Others IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 98 Italy IVD Market, by Application, 2016 - 2027 (USD Million)
TABLE 99 Italy IVD Market, by End-use, 2016 - 2027 (USD Million)
TABLE 100 Russia IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 101 Russia IVD Market, by Technique, 2016 - 2027 (USD Million)
TABLE 102 Russia Immunoassay IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 103 Russia Hematology IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 104 Russia Clinical Chemistry IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 105 Russia Molecular Diagnostics IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 106 Russia Coagulation IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 107 Russia Microbiology IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 108 Russia Others IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 109 Russia IVD Market, by Application, 2016 - 2027 (USD Million)
TABLE 110 Russia IVD Market, by End-use, 2016 - 2027 (USD Million)
TABLE 111 Asia Pacific IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 112 Asia Pacific IVD Market, by Technique, 2016 - 2027 (USD Million)
TABLE 113 Asia Pacific Immunoassay IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 114 Asia Pacific Hematology IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 115 Asia Pacific Clinical Chemistry IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 116 Asia Pacific Molecular Diagnostics IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 117 Asia Pacific Coagulation IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 118 Asia Pacific Microbiology IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 119 Asia Pacific Others IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 120 Asia Pacific IVD Market, by Application, 2016 - 2027 (USD Million)
TABLE 121 Asia Pacific IVD Market, by End-use, 2016 - 2027 (USD Million)
TABLE 122 Japan IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 123 Japan IVD Market, by Technique, 2016 - 2027 (USD Million)
TABLE 124 Japan Immunoassay IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 125 Japan Hematology IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 126 Japan Clinical Chemistry IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 127 Japan Molecular Diagnostics IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 128 Japan Coagulation IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 129 Japan Microbiology IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 130 Japan Others IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 131 Japan IVD Market, by Application, 2016 - 2027 (USD Million)
TABLE 132 Japan IVD Market, by End-use, 2016 - 2027 (USD Million)
TABLE 133 China IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 134 China IVD Market, by Technique, 2016 - 2027 (USD Million)
TABLE 135 China Immunoassay IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 136 China Hematology IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 137 China Clinical Chemistry IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 138 China Molecular Diagnostics IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 139 China Coagulation IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 140 China Microbiology IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 141 China Others IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 142 China IVD Market, by Application, 2016 - 2027 (USD Million)
TABLE 143 China IVD Market, by End-use, 2016 - 2027 (USD Million)
TABLE 144 India IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 145 India IVD Market, by Technique, 2016 - 2027 (USD Million)
TABLE 146 India Immunoassay IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 147 India Hematology IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 148 India Clinical Chemistry IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 149 India Molecular Diagnostics IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 150 India Coagulation IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 151 India Microbiology IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 152 India Others IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 153 India IVD Market, by Application, 2016 - 2027 (USD Million)
TABLE 154 India IVD Market, by End-use, 2016 - 2027 (USD Million)
TABLE 155 South Korea IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 156 South Korea IVD Market, by Technique, 2016 - 2027 (USD Million)
TABLE 157 South Korea Immunoassay IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 158 South Korea Hematology IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 159 South Korea Clinical Chemistry IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 160 South Korea Molecular Diagnostics IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 161 South Korea Coagulation IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 162 South Korea Microbiology IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 163 South Korea Others IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 164 South Korea IVD Market, by Application, 2016 - 2027 (USD Million)
TABLE 165 South Korea IVD Market, by End-use, 2016 - 2027 (USD Million)
TABLE 166 Singapore IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 167 Singapore IVD Market, by Technique, 2016 - 2027 (USD Million)
TABLE 168 Singapore Immunoassay IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 169 Singapore Hematology IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 170 Singapore Clinical Chemistry IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 171 Singapore Molecular Diagnostics IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 172 Singapore Coagulation IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 173 Singapore Microbiology IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 174 Singapore Others IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 175 Singapore IVD Market, by Application, 2016 - 2027 (USD Million)
TABLE 176 Singapore IVD Market, by End-use, 2016 - 2027 (USD Million)
TABLE 177 Australia IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 178 Australia IVD Market, by Technique, 2016 - 2027 (USD Million)
TABLE 179 Australia Immunoassay IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 180 Australia Hematology IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 181 Australia Clinical Chemistry IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 182 Australia Molecular Diagnostics IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 183 Australia Coagulation IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 184 Australia Microbiology IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 185 Australia Others IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 186 Australia IVD Market, by Application, 2016 - 2027 (USD Million)
TABLE 187 Australia IVD Market, by End-use, 2016 - 2027 (USD Million)
TABLE 188 Latin America IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 189 Latin America IVD Market, by Technique, 2016 - 2027 (USD Million)
TABLE 190 Latin America Immunoassay IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 191 Latin America Hematology IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 192 Latin America Clinical Chemistry IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 193 Latin America Molecular Diagnostics IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 194 Latin America Coagulation IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 195 Latin America Microbiology IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 196 Latin America Others IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 197 Latin America IVD Market, by Application, 2016 - 2027 (USD Million)
TABLE 198 Latin America IVD Market, by End-use, 2016 - 2027 (USD Million)
TABLE 199 Brazil IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 200 Brazil IVD Market, by Technique, 2016 - 2027 (USD Million)
TABLE 201 Brazil Immunoassay IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 202 Brazil Hematology IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 203 Brazil Clinical Chemistry IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 204 Brazil Molecular Diagnostics IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 205 Brazil Coagulation IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 206 Brazil Microbiology IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 207 Brazil Others IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 208 Brazil IVD Market, by Application, 2016 - 2027 (USD Million)
TABLE 209 Brazil IVD Market, by End-use, 2016 - 2027 (USD Million)
TABLE 210 Mexico IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 211 Mexico IVD Market, by Technique, 2016 - 2027 (USD Million)
TABLE 212 Mexico Immunoassay IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 213 Mexico Hematology IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 214 Mexico Clinical Chemistry IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 215 Mexico Molecular Diagnostics IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 216 Mexico Coagulation IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 217 Mexico Microbiology IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 218 Mexico Others IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 219 Mexico IVD Market, by Application, 2016 - 2027 (USD Million)
TABLE 220 Mexico IVD Market, by End-use, 2016 - 2027 (USD Million)
TABLE 221 Argentina IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 222 Argentina IVD Market, by Technique, 2016 - 2027 (USD Million)
TABLE 223 Argentina Immunoassay IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 224 Argentina Hematology IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 225 Argentina Clinical Chemistry IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 226 Argentina Molecular Diagnostics IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 227 Argentina Coagulation IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 228 Argentina Microbiology IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 229 Argentina Others IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 230 Argentina IVD Market, by Application, 2016 - 2027 (USD Million)
TABLE 231 Argentina IVD Market, by End-use, 2016 - 2027 (USD Million)
TABLE 232 MEA IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 233 MEA IVD Market, by Technique, 2016 - 2027 (USD Million)
TABLE 234 MEA Immunoassay IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 235 MEA Hematology IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 236 MEA Clinical Chemistry IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 237 MEA Molecular Diagnostics IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 238 MEA Coagulation IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 239 MEA Microbiology IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 240 MEA Others IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 241 MEA IVD Market, by Application, 2016 - 2027 (USD Million)
TABLE 242 MEA IVD Market, by End-use, 2016 - 2027 (USD Million)
TABLE 243 South Africa IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 244 South Africa IVD Market, by Technique, 2016 - 2027 (USD Million)
TABLE 245 South Africa Immunoassay IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 246 South Africa Hematology IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 247 South Africa Clinical Chemistry IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 248 South Africa Molecular Diagnostics IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 249 South Africa Coagulation IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 250 South Africa Microbiology IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 251 South Africa Others IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 252 South Africa IVD Market, by Application, 2016 - 2027 (USD Million)
TABLE 253 South Africa IVD Market, by End-use, 2016 - 2027 (USD Million)
TABLE 254 UAE IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 255 UAE IVD Market, by Technique, 2016 - 2027 (USD Million)
TABLE 256 UAE Immunoassay IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 257 UAE Hematology IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 258 UAE Clinical Chemistry IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 259 UAE Molecular Diagnostics IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 260 UAE Coagulation IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 261 UAE Microbiology IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 262 UAE Others IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 263 UAE IVD Market, by Application, 2016 - 2027 (USD Million)
TABLE 264 UAE IVD Market, by End-use, 2016 - 2027 (USD Million)
TABLE 265 Saudi Arabia IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 266 Saudi Arabia IVD Market, by Technique, 2016 - 2027 (USD Million)
TABLE 267 Saudi Arabia Immunoassay IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 268 Saudi Arabia Hematology IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 269 Saudi Arabia Clinical Chemistry IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 270 Saudi Arabia Molecular Diagnostics IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 271 Saudi Arabia Coagulation IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 272 Saudi Arabia Microbiology IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 273 Saudi Arabia Others IVD Market, by Product, 2016 - 2027 (USD Million)
TABLE 274 Saudi Arabia IVD Market, by Application, 2016 - 2027 (USD Million)
TABLE 275 Saudi Arabia IVD Market, by End-use, 2016 - 2027 (USD Million)


★調査レポート[体外診断薬の世界市場:製品別、技術別(分子診断、臨床化学)、用途別、エンドユーザー別] (コード:GVR20MA087)販売に関する免責事項を必ずご確認ください。
★調査レポート[体外診断薬の世界市場:製品別、技術別(分子診断、臨床化学)、用途別、エンドユーザー別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆